Erk1/2 Orchestrates SSPH I‐Induced Oxidative Stress, Mitochondrial Dysfunction and Ferroptosis in Hepatocellular Carcinoma
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Yuewen Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi University of Chinese Medicine, Nanning, China. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms, Oxidative Stress. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Province, Young talents in Gui Pai Xing lin of Guangxi University of Chinese Medicine.
Abstract (Originalsprache)
Although Erk1/2 has been linked to oxidative stress regulation in hepatocellular carcinoma (HCC), the interplay among Erk1/2, reactive oxygen species (ROS), and iron metabolism remains poorly characterised. The steroidal saponin SSPH I, a recognised ferroptosis inducer, exerts dual pharmacological effects via Erk1/2 and ROS‐dependent pathways. This study aimed to investigate the regulatory mechanisms of Erk1/2 in ferroptosis and oxidative stress and analyse their feedback regulatory effects on Erk1/2 in HCC using SSPH I as a pharmacological probe, and further elucidate the anti‐HCC effects and mechanisms of SSPH I in vitro and in vivo. Mechanistic studies utilised three inhibitors: U0126 (Erk1/2 phosphorylation inhibitor), Ferrostatin‐1 (ferroptosis inhibitor), and N‐acetyl cysteine (ROS scavenger), combined with SSPH I to delineate its effects on cell viability, mitochondrial dynamics, ferroptosis induction and oxidative stress. Mechanistically, SSPH I disrupted mitochondrial function and suppressed HCC cell survival through iron accumulation and ROS generation, while concurrently activating Erk1/2 signalling. Pharmacological inhibition of ROS or iron pathways partially attenuated SSPH I‐induced ferroptosis and ROS generation, but failed to abrogate these effects. Erk1/2 inhibition completely abolished SSPH I‐mediated regulation of the Nrf1/2‐HO‐1 axis and ferroptosis‐related protein expression in cellular and animal models, identifying Erk1/2 as the upstream regulatory node. Notably, while both SSPH I and U0126 monotherapies inhibited xenograft growth, their combined use resulted in antagonistic effects. These findings establish Erk1/2 activation as the central molecular mechanism orchestrating SSPH I‐driven oxidative stress amplification, mitochondrial dysfunction and ferroptosis execution in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi University of Chinese Medicine, Nanning, China.
- Guangxi Vocational University of Agriculture, Nanning, China.
- Yunnan Grassroots Medical Industry Development Co. Ltd, Kunming, China.
ORCID-Profile: Yuewen Sun
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
- Young talents in Gui Pai Xing lin of Guangxi University of Chinese Medicine
- Qihuang Project Team of Guangxi University of Chinese Medicine
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
Zitieren
APA
Sun, Y., Zhou, Y., Huang, D., Zhao, Z., Shao, Q., Li, J., Zhao, X., & Liu, X. (2025). Erk1/2 Orchestrates SSPH I‐Induced Oxidative Stress, Mitochondrial Dysfunction and Ferroptosis in Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70609
Vancouver
Sun Y, Zhou Y, Huang D, Zhao Z, Shao Q, Li J, et al. Erk1/2 Orchestrates SSPH I‐Induced Oxidative Stress, Mitochondrial Dysfunction and Ferroptosis in Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70609
BibTeX
@article{Sun2025,
author = {Sun, Yuewen and Zhou, Ying and Huang, Dan and Zhao, Zhiguang and Shao, Qingrui and Li, Jianzhe and Zhao, Xiaofang and Liu, Xudong},
title = {Erk1/2 Orchestrates SSPH I‐Induced Oxidative Stress, Mitochondrial Dysfunction and Ferroptosis in Hepatocellular Carcinoma},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70609}
}
EUVIMED